Prometheus Therapeutics Inc.
About
Issuer
- Entity type
- Corporation
- Jurisdiction
- Delaware
- Sector
- Healthtech
- Headquarters
- Miramar, FL
- Street
- 10370 USA Today Way
- Zip
- 33025
Offering
- Total offering
- $6.5M
- Amount sold
- $2.7M
- First sale
- Oct 28, 2025
- Min investment
- $0
- Securities
- —
- Federal exemption
- Rule 506(b)
- Investors so far
- 13
How this filing compares
Ranked #18 of 63 Healthtech filings in April 2026 by offering amount.
Median Healthtech filing in April 2026: $3.4M. This offering is 1.9× the median.
Other Florida filings this week: Creative Health Real Estate Fund I LLC, CRESTLINE REAL ESTATE 2026 LP, FC Indigo Huntsville JV, LLC, FC Tillinghast Cir JV, LLC, Fraud Protection Network, Inc.
Leadership
Ajay Wakhloo — Executive Officer (also: Director)
Also named on: NeuroFine Corp.
Alexander Hastings — Director
Baruch Lieber — Executive Officer (also: Director)
John McEleney — Director
Also named on: NeuroFine Corp.
Bernie Navarro — Executive Officer
Also named on: NeuroFine Corp.
Filing details
Prometheus Therapeutics Inc. filed a Form D with the SEC on April 15, 2026.